Literature DB >> 11231919

Effect of probucol in lecithin-cholesterol acyltransferase-deficient mice: inhibition of 2 independent cellular cholesterol-releasing pathways in vivo.

S Tomimoto1, M Tsujita, M Okazaki, S Usui, T Tada, T Fukutomi, S Ito, M Itoh, S Yokoyama.   

Abstract

Cellular cholesterol release takes place by at least 2 distinct mechanisms: the lecithin-cholesterol acyltransferase (LCAT)-driven net efflux by cholesterol diffusion and the generation of high density lipoprotein (HDL) with cellular cholesterol and phospholipid on the cell-apolipoprotein interaction. Therefore, LCAT deficiency impairs the former pathway, and the latter can be inhibited by probucol, which interferes with the apolipoprotein-cell interaction. Hence, probucol was given to the LCAT-deficient mice in the attempt to suppress both of these pathways. The mice were fed low (0.2%) and high (1.2%) cholesterol diets containing 0.5% probucol for 2 weeks. LCAT deficiency and probucol markedly decreased plasma HDL, and the effects were synergistic. Tissue cholesterol content was lower in the adrenal glands and ovaries in the LCAT-deficient mice and in the probucol-treated mice, suggesting that HDL is a main cholesterol provider for these organs. It was also moderately decreased in the spleen of the low cholesterol-fed female mice and in the thyroid gland of the low cholesterol-fed male mice. On the other hand, the esterified cholesterol content in the liver was substantially increased by the probucol treatment with a high cholesterol diet in the LCAT-deficient mice but not in the wild-type mice. Among the groups, there was no significant difference in the tissue cholesterol levels in other organs, such as the liver, spleen, thymus, brain, erythrocytes, thyroid gland, testis, and aorta, resulting from either LCAT deficiency or probucol. Thus, the apolipoprotein-mediated mechanism plays a significant role in the export of cellular cholesterol in the liver, indicating that the liver is a major site of the HDL assembly. Otherwise, tissue cholesterol homeostasis can largely be maintained in mice even when the assembly of new HDL is inhibited by probucol in the absence of LCAT. Nonspecific diffusion of cholesterol perhaps adequately maintains the homeostasis in the experimental condition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11231919     DOI: 10.1161/01.atv.21.3.394

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  5 in total

1.  Probucol prevents early coronary heart disease and death in the high-density lipoprotein receptor SR-BI/apolipoprotein E double knockout mouse.

Authors:  Anne Braun; Songwen Zhang; Helena E Miettinen; Shamsah Ebrahim; Teresa M Holm; Eliza Vasile; Mark J Post; Danita M Yoerger; Michael H Picard; Joshua L Krieger; Nancy C Andrews; Michael Simons; Monty Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-27       Impact factor: 11.205

2.  Pharmacological inhibition of ABCA1 degradation increases HDL biogenesis and exhibits antiatherogenesis.

Authors:  Reijiro Arakawa; Maki Tsujita; Noriyuki Iwamoto; Chisato Ito-Ohsumi; Rui Lu; Chen-Ai Wu; Kenji Shimizu; Tomoji Aotsuka; Hashime Kanazawa; Sumiko Abe-Dohmae; Shinji Yokoyama
Journal:  J Lipid Res       Date:  2009-05-20       Impact factor: 5.922

3.  Probucol therapy overcomes the reproductive defect in CTP: phosphocholine cytidylyltransferase beta2 knockout mice.

Authors:  Christopher Gunter; Matthew Frank; Yong Tian; K Gopal Murti; Jerold E Rehg; Suzanne Jackowski
Journal:  Biochim Biophys Acta       Date:  2007-05-10

4.  Hydroxypropyl-β-cyclodextrin protects from kidney disease in experimental Alport syndrome and focal segmental glomerulosclerosis.

Authors:  Alla Mitrofanova; Judith Molina; Javier Varona Santos; Johanna Guzman; Ximena A Morales; G Michelle Ducasa; Jonathan Bryn; Alexis Sloan; Ion Volosenco; Jin-Ju Kim; Mengyuan Ge; Shamroop K Mallela; Matthias Kretzler; Sean Eddy; Sebastian Martini; Patricia Wahl; Santiago Pastori; Armando J Mendez; George W Burke; Sandra Merscher; Alessia Fornoni
Journal:  Kidney Int       Date:  2018-10-06       Impact factor: 10.612

5.  Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT.

Authors:  Maki Tsujita; Boris Vaisman; Liu Chengyu; Kasey C Vickers; Kei-Ichiro Okuhira; Sten Braesch-Andersen; Alan T Remaley
Journal:  FEBS Lett       Date:  2020-10-20       Impact factor: 4.124

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.